v3.22.4
NET SALES (Tables)
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Summary of Contract Assets and Liabilities
The following table summarizes our contract assets:
as of December 31 (in millions)20222021
Contract manufacturing services$51 $50 
Software sales43 45 
Bundled equipment and consumable medical products contracts121 100 
Contract assets$215 $195 
The following table summarizes the classification of contract assets and contract liabilities as reported in the consolidated balance sheet:
as of December 31 (in millions)20222021
Prepaid expenses and other current assets$93 $84 
Other non-current assets122 111 
Contract assets$215 $195 
Accrued expenses and other current liabilities$164 $162 
Other non-current liabilities80 84 
Contract liabilities$244 $246 
The following table summarizes contract liability activity for the year ended December 31, 2022. The contract liability balance represents the transaction price allocated to the remaining performance obligations.
year ended December 31 (in millions)2022
Balance at beginning of period$246 
New revenue deferrals666 
Revenue recognized upon satisfaction of performance obligations(662)
Currency translation(6)
Balance at end of period$244 
Disaggregation of Revenue
The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:
202220212020
years ended December 31 (in millions)U.S.InternationalTotalU.S.InternationalTotalU.S.InternationalTotal
Renal Care1
$945 $2,803 $3,748 $890 $3,010 $3,900 $848 $2,909 $3,757 
Medication Delivery2
1,889 997 2,886 1,859 1,021 2,880 1,738 953 2,691 
Pharmaceuticals3
682 1,444 2,126 753 1,538 2,291 849 1,249 2,098 
Clinical Nutrition4
352 579 931 343 621 964 330 580 910 
Advanced Surgery5
574 424 998 545 432 977 516 370 886 
Acute Therapies6
241 460 701 287 495 782 286 454 740 
BioPharma Solutions7
305 339 644 273 396 669 234 252 486 
Patient Support Systems8
1,150 337 1,487 86 29 115 — — — 
Front Line Care9
840 308 1,148 51 19 70 — — — 
Surgical Solutions10
145 159 304 12 15 27 — — — 
Other11
100 40 140 81 28 109 77 28 105 
Total Baxter$7,223 $7,890 $15,113 $5,180 $7,604 $12,784 $4,878 $6,795 $11,673 
1    Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.
2    Medication Delivery includes sales of our IV therapies, infusion pumps, administration sets and drug reconstitution devices.
3    Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.
4    Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.
5    Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.
6    Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).
7    BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.
8    Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies and smart beds.
9    Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.
10    Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.
11    Other includes sales of miscellaneous product and service offerings.